U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300189) titled 'A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects' on Dec. 10.
Brief Summary: This phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-ascending doses in healthy subjects.
Study Start Date: Nov. 06
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: TLC-1180 Oral Solution
Oral solution of TLC-1180
DRUG: TLC-1180 Tablet
Tablet formulation of TLC-1180
OTHER: Placebo Oral Solution
Placebo-to-match oral solution TLC-1180
OTHER: Placebo Tablet
Placebo-to-match tablet formu...